Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3916 USD | -0.23% | +5.04% | -13.93% |
Evolution of the average Target Price on Galmed Pharmaceuticals Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Galmed Pharmaceuticals Ltd.
Maxim | |
Canaccord Genuity | |
Cantor Fitzgerald | |
Raymond James | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- GLMD Stock
- Consensus Galmed Pharmaceuticals Ltd.